黄斑虫的刺伤和β-阻断剂的使用.

Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.

Substance abuse treatment, prevention, and policy·2024

Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).

Clinical and experimental immunology·2018

The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017.

Clinical and experimental immunology·2018

Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy.

Clinical and experimental immunology·2017

Antibody deficiency in Rubinstein-Taybi syndrome.

Clinical genetics·2015

T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.

Clinical and experimental immunology·2014

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Zoonotic dermatophyte Trichophyton erinacei in pet hedgehogs: sampling methodology and further insight into genetic diversity.

Frontiers in veterinary science·2026

Asynchronous local differences in Lyme disease environmental hazard driven by variation in tick abundance and Borrelia burgdorferi infection prevalence.

Parasites & vectors·2026

Immunogenicity and safety of serum-free rabies vaccine for human use with simulated post-exposure schedules: A randomized, double-blind, active-controlled phase III clinical trial.

Vaccine·2026

Siglec-5 suppresses LPS-induced acute lung injury via negative regulation of HSF1/SYK-mediated ROS production and pyroptosis.

Frontiers in medicine·2026

Clinical Impact of Measurement Timing on Intraocular Pressure in Dogs.

Veterinary ophthalmology·2026

Concurrent Babesia gibsoni infection as a negative prognostics indicator of survival in dogs diagnosed with immune-mediated hemolytic anemia: A prospective cohort study.

Topics in companion animal medicine·2026

相关实验视频

黄斑虫的刺伤和β-阻断剂的使用

相关概念视频

Prescribed safer supply during dual public health emergencies: a qualitative study examining service providers perspectives on early implementation.

Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia).

The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017.

Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy.

Antibody deficiency in Rubinstein-Taybi syndrome.

T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Zoonotic dermatophyte Trichophyton erinacei in pet hedgehogs: sampling methodology and further insight into genetic diversity.

Asynchronous local differences in Lyme disease environmental hazard driven by variation in tick abundance and Borrelia burgdorferi infection prevalence.

Immunogenicity and safety of serum-free rabies vaccine for human use with simulated post-exposure schedules: A randomized, double-blind, active-controlled phase III clinical trial.

Siglec-5 suppresses LPS-induced acute lung injury via negative regulation of HSF1/SYK-mediated ROS production and pyroptosis.

Clinical Impact of Measurement Timing on Intraocular Pressure in Dogs.

Concurrent Babesia gibsoni infection as a negative prognostics indicator of survival in dogs diagnosed with immune-mediated hemolytic anemia: A prospective cohort study.

相关实验视频

黄斑虫的刺伤和β-阻断剂的使用

相关概念视频

相关文章